Canadian biotech firms' creative capacity: On the role of absorptive capacity, relational capital, learning, and firm characteristics

International Journal of Biotechnology

Volumn 6, Issue 1, 2004, Pages 1-19

  Traoré, Namatié ^a  

^a STATISTICS CANADA   (Canada)

Author keywords

Absorptive capacity; Biotechnology Firm Survey; Canadian biotech firms; Creative capacity; Learning; Product development stage; Relational capital; Statistics Canada

Indexed keywords

INTERNATIONAL TRADE; MARKETING; PRODUCT DEVELOPMENT; RESEARCH AND DEVELOPMENT MANAGEMENT;

ABSORPTIVE CAPACITY; CANADIAN BIOTECH FIRMS;

BIOTECHNOLOGY;

BIOTECHNOLOGY; INDUSTRIAL PERFORMANCE; LEARNING; PRODUCT DEVELOPMENT; SCIENCE AND TECHNOLOGY;

BIOTECHNOLOGY; CANADA; CAPITAL; COMMERCIAL PHENOMENA; CREATIVITY; LEARNING; MARKET; RESEARCH; REVIEW; STATISTICS;

CANADA; NORTH AMERICA;

EID: 3042744195     PISSN: 09636048     EISSN: None     Source Type: Journal    
DOI: 10.1504/IJBT.2004.004609     Document Type: Review

References (42)

1. Traoré, N. (2001) Canadian Biotechnology Industrial Activities: Features From the 1997 Biotechnology Survey, Research paper No. 12, Statistics Canada, SIEID.
2. Traoré, N. and Antoine, R. (2003) 'Determinants of biotechnology utilization by the Canadian industry', Research Policy, Vol. 32, No. 10, pp. 1719-1735.
3. Arundel, A. (1999) Diffusion of Biotechnology in Canada: Results from the Survey of Biotechnology Use in Canadian Industries - 1996, Working paper No. 06, Science, Innovation and Electronic Information Division (SIEID), Statistics Canada.
4. Rose, A. (1996) Biotechnology Use by Canadian Industry - 1996, Working paper No. 05, Science Innovation and, Electronic Information Division (SIEID), Statistics Canada.
5. Arundel, A. and Rose, R. (1999) 'The diffusion of environmental biotechnology in Canada: adoption strategies and cost offsets', Technovation, Vol. 19, pp.551-560.
6. McNiven, C. (2001) Biotechnology Use and Development - 1999, Working paper No. 7, Science Innovation and, Electronic Information Division (SIEID), Statistics Canada.
7. McNiven, C. (2001) Practices and Activities of Canadian Biotechnology Firms: Results from the Biotechnology Use and Development Survey - 1999, Working paper No. 11, Science, Innovation and Electronic Information Division (SIEID), Statistics Canada.
8. McNiven, C. (2002) Use of Biotechnologies in the Canadian Industrial Sector: results from the Biotechnology Use and Development Survey - 1999, Statistics Canada, SIEID.
9. Byrd, C. (2002) Results from the Biotechnology Use and Development Survey - 1999: Profile of Spin-off Firms in Biotechnology, Statistics Canada, SIEID.
10. Niosi, J. (2000) Explaining Rapid Growth in Canadian Biotechnology Firms, Research Paper No. 8, Statistics Canada, SIEID.
11. Statistics Canada (2001) 'Biotechnology research and development (R&D) in Canada industry 1998', Science Statistics Service Bulletin, Vol. 25, No. 4.
12. Niosi, J. and Bas, T.G. (2001) 'The competencies of regions: Canada's clusters in Biotechnology', Small Business Economics, Vol. 17, pp.31-42.
13. Ittner, C. and Larcker, D. (2000) Non-financial Performance Measures: What Works and What Doesn't, Reginal H. Jones Center for Management Policy Strategy and Organization, Warton, University of Pennsylvania, PA.
14. Deeds, L.D. (2001) 'The role of R&D intensity, technical development and absorptive capacity in creating entrepreneurial wealth in technology start-ups', Journal of Engineering and Technology Management, Vol. 18.
15. Meyer, W.M. (1997) Dilemmas of Performance measurement, Reginal H. Jones Center for Management Policy Strategy and Organization, Working Paper 97-02, Warton, University of Pennsylvania, PA.
16. Bosworth, D. and Rogers, M. (2001) 'Market value, R&D and intellectual property: an empirical analysis of large australian firms', The Economic Record, Vol. 77, No. 239, pp.323-337.
17. Griliches, Z. (1981) 'Market value, R&D, and patents', Economic Letters, Vol. 7, pp.183-187.
18. Hall, B. (2000) 'Innovation and market value', in Barrelll, R., Mason, G. and O'Mahoney, M. (Eds.): Productivity, Innovation and Economic Performance, Cambridge University Press, Cambridge, UK, pp. 177-198.
19. Stuart, E.T. (2000) Interorganizational Alliances and the Performance of Firms: A study of Growth and Innovation in a High-Technology Industry, Graduate School of Business, University of Chicago, Chicago, IL.
20. Blundell, R., Griffith, R. and Reenen, J.V. (1998), Market Share, Market Value and Innovation in a Panel British Manufacturing Firms, University College, London, UK.
21. Powell, W.W. et al. (1998) 'Learning from collaboration: knowledge and networks in the biotechnology and pharmaceutical industries', California Management Review, Vol. 40, No. 3, pp.228-240.
22. Smith, V., Dilling-hansen, M., Erikson, T. and Madsen, E.S. (2000) R&D and Productivity in Danish Firms: Some Empirical Evidence, Danish Institute for Studies in Research and Research policy, Aarhus.
23. Feeny, S. and Mark, R. (2001) Innovation and Performance: Benchmarking Australian Firms, Merlbourne Institute of Applied Economic and Social Research, Working Paper 7/01, The University of Melbourne, Victoria, Australia.
24. Austin, H.D. (2000) Patents, Spillovers, and Competition in Biotechnology, Discussion Paper 00-53, Resources for the Future, Washington, D.C., USA.
25. Zucker, G.L., Darby, M.R. and Armstrong, J.S. (2001) Commercializing Knowledge: University Science, Knowledge Capture, and Firm Performance in Biotechnology, National Bureau of Economic Research, Working Paper 8499, Cambridge, MA.
26. Zucker, G.L. and Darby, M.R. (1998) Capturing Technological Opportunity Via Japan's Star Scientists: Evidence from Japanese Firms' Biotech patents and Products, NBER Working Paper Series, Working Paper 6360.
27. Zucker, G.L., Darby, M.R. and Armstrong, J. (1994) Intellectual Capital and the Firm: The Technology of Geographically Localized Knowledge Spillovers, National Bureau of Economic Research Working Paper Series, Working Paper 4946.
28. Liebeskind, P.J., Zucker, L.G., Oliver, A.L. and Brewer, M.B. (1995) Social Networks, Learning, and Flexibility: Sourcing Scientific Knowledge in New Biotechnology Firms, NBER Working Paper Series, Working Paper 5320.
29. Zucker, G.L., Darby, M.R., Brewer, M.B. and Peng, Y. (1995) Collaboration Structure and Information Dilemmas in Biotechnology: Organizational Boundaries as Trust Production, National Bureau of Economic Research, Working Paper 5199.
30. Statistics Canada, Science and Technology Redesign Project (1997) Biotechnology Firm Survey - 1997, Statistics Canada.
31. Lohr, L.S. (1999) Sampling: Design and Analysis, Duxbury Press, Albany, New York, USA, pp.269-274.
32. Ernst and Young (1997) Canadian Biotech' 97: Coming of Age, Fourth Report on the Canadian Biotechnology Industry, Goudey, J. and Deepika Nath.
33. Contact Canada (1998) Canadian Biotechnology 1998, Fred Haynes.
34. Wingnean, D. and Lun, E. (2001) The Canadian Biotechnology and Health care Industry, TD Securities Inc.: A subsidiary of the Toronto-Dominion Bank.
35. Rocha, F. (1997) Inter-Firm Technological Cooperation: Effects of Absorptive Capacity, Firm-Size and Specialization, Discussion Paper Series No. 9707, The United Nation University, Institute for New Technologies.
36. Artz, W.K., Duane Ireland, R. and Hitt, M.A. (1999) International Diversity by Entrepreneurial Firms: Cooperative Relationships, Core Competencies and Performance, Hankamer School of Business, Baylor University, Waco, Texas, USA.
37. Rachel, G., Redding, S. and Reenen, J.V. (2000) R&D and Absorptive Capacity: From Theory to Data, The Institute for Fiscal Studies, Working Paper 01/03.
38. Cohen, W. and Levinthal, R. (1989) 'Empirical studies of innovation and market structure', in Schmalensee and Willig (Eds.): The Handbook of Industrial Organization, Vol. 1, Amsterdam, North Holland.
39. Song, J., Almeida, P. and Wu, G. (2001) Learning by Hiring: When is Mobility Useful? http://www.google.com/search?q=jaeyongsongpdf
40. Nelson, R.R. and Winter, S.G. (1982) An Evolutionary Theory of Economic Change, The Belknap Press, Cambridge, MA.
41. Fountain, E.J. (1997) 'Relational capital: a key enabler of innovation in science and technology', in Branscomb, L.M. and Keller, J. (Eds): Investing in Innovation: Toward a Consensus Strategy for Federal Technology Policy, The MIT Press, Cambridge.
42. Powell, W.W., Koput, K.W. and Smith-Doerr, L. (1996) 'Interorganizational collaboration and the locus of innovation: networks of learning in biotechnology', Administrative Science Quarterly, Vol. 41, pp. 116-145.